CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Acuitas Therapeutics Inc. v. GlaxoSmithKline Biologicals SA

1:25-cv-00003

Overview

Case Number 1:25-cv-00003
Filing Date 2025-01-02
Status Terminated
Termination Date 2026-09-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand Plaintiff

Parties

Defendant

GlaxoSmithKline LLC NPE (University / Research)

Represented By

4 Attorneys Listed

Michael E. Furrow

Email: mfurrow@desmaraisllp.com

David J. Shaw

Email: dshaw@desmaraisllp.com

Sara M. Metzler

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7869
Fax: +1 (302) 498-7869

Richards, Layton & Finger, PA, One Rodney Square

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

GlaxoSmithKline Biologicals SA NPE (University / Research)

Represented By

4 Attorneys Listed

Michael E. Furrow

Email: mfurrow@desmaraisllp.com

David J. Shaw

Email: dshaw@desmaraisllp.com

Sara M. Metzler

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7869
Fax: +1 (302) 498-7869

Richards, Layton & Finger, PA, One Rodney Square

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Acuitas Therapeutics Inc. Operating Company

Represented By

12 Attorneys Listed

Saurabh Gupta

Email: saurabh.gupta@groombridgewu.com

Nisha Gera

Email: nisha.gera@groombridgewu.com

Nicholas Groombridge

Email: Nick.groombridge@groombridgewu.com

Josephine Young

Email: josephine.young@groombridgewu.com

Eric Alan Stone

Email: eric.stone@groombridgewu.com

Chih-Wei Wu

Email: chihwei.wu@groombridgewu.com

Ariella Barel

Email: ariella.barel@groombridgewu.com

Allison C. Penfield

Email: allison.penfield@groombridgewu.com

Stephanie Vangellow

Young Conaway

Tel: +1 (302) 571-6667

Young Conaway, 1000 North King St

James L. Higgins

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5034

Rodney Square, 1000 North King Street

Catherine Lynch

Young Conaway Stargatt & Taylor, LLP

Tel: +1 (302) 571-6600

1000 N. King Street, Wilmington, DE 19801

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

8 Patents

There are 8 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11638693
Vaccine for eliciting immune response comprising RNA encoding an immunogen and lipid formulations comprising mole percentage of lipids
Filed: 2022-06-23
Issued: 2023-05-02
Active (4.6 yrs remaining)
Expires: 2031-07-06
US11638694
Vaccine for eliciting immune response comprising lipid formulations and RNA encoding multiple immunogens
Filed: 2022-06-23
Issued: 2023-05-02
Active (4.6 yrs remaining)
Expires: 2031-07-06
US11666534
Methods of administering lipid formulations with viral immunogens
Filed: 2021-12-22
Issued: 2023-06-06
Active (15.1 yrs remaining)
Expires: 2041-12-22
US11766401
Methods of administering lipid formulations with immunogens
Filed: 2021-12-22
Issued: 2023-09-26
Active (15.1 yrs remaining)
Expires: 2041-12-22
US11786467
Lipid formulations with immunogens
Filed: 2021-12-22
Issued: 2023-10-17
Active (15.1 yrs remaining)
Expires: 2041-12-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

20

Dispositive

14

Granted

3

Denied

0

Pending / Review

14

Motions by Category

Procedural / Extension Motion 6 Motion to Dismiss 14

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORAL ORDER: Having considered Plaintiff's Motion for Leave to File its Amended Complaint Under Seal ("Motion") (D.I. 27), IT IS HEREBY ORDERED that Plaintiff's ...
Entry #52 • 2026-03-12 Document →
Motion to Dismiss Pending / Under Review
Letter to The Honorable Gregory B. Williams from Melanie K. Sharp regarding Request for Oral Argument - re 33 MOTION to Dismiss for Lack of Jurisdiction Over th...
Entry #42 • 2025-05-22 Document →
Motion to Dismiss Pending / Under Review
REDACTED VERSION of 38 Answering Brief in Opposition, of Defendants' Motion to Dismiss Plaintiff's First Amended Complaint by Acuitas Therapeutics Inc.. (Attach...
Entry #40 • 2025-05-15 Document →
Motion to Dismiss Pending / Under Review
[SEALED] REPLY BRIEF re 33 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter (First Amended Complaint) filed by GlaxoSmithKline Biologicals SA,...
Entry #41 • 2025-05-15 Document →
Motion to Dismiss Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 33 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter (First Amended Complaint) filed by Acuitas Thera...
Entry #38 • 2025-05-08 Document →
Motion to Dismiss Pending / Under Review
STIPULATION [and Proposed Order] That The Parties May File Any Remaining Briefing and Related Papers on GlaxoSmithKline LLC's Motion to Dismiss Actuitas's First...
Entry #37 • 2025-05-07 Document →

Docket Entries

(105 total)
Procedural / Extension Motion Granted

MOTION for Leave to File Complaint Under Seal - filed by Acuitas Therapeutics Inc. (Attachments: # 1 Proposed Order)(oam) Modified on 1/2/2025 (nms). (Entered: 01/02/2025)

Entry #1 • 2025-01-02
1
Pleading / Complaint

[SEALED] COMPLAINT for Declaratory Judgment of Non-Infringement and Invalidity with Jury Demand against GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC (Filing fee $ 405, receipt number ADEDC-4580889) - filed by Acuitas Therapeutics Inc.(Attachments: # 1 Exhibit F, # 2 Exhibit G, # 3 Exhibit H)(oam) # 4 Civil Cover Sheet) (oam). (Entered: 01/02/2025)

Entry #2 • 2025-01-02
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 01/02/2025)

Entry #3 • 2025-01-02
1
Pleading / Complaint

EXHIBITS A-E to 2 Complaint, filed by Acuitas Therapeutics Inc. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E)(oam) Modified on 1/2/2025 (nms). (Entered: 01/02/2025)

Entry #4 • 2025-01-02
1
Pleading / Complaint

EXHIBITS A-E to 2 Complaint, filed by Acuitas Therapeutics Inc. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E)(oam) Modified on 1/2/2025 (nms). (Entered: 01/02/2025)

Entry #4 • 2025-01-02
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc